trending Market Intelligence /marketintelligence/en/news-insights/trending/znjdiijp0l82yb35sao36g2 content esgSubNav
In This List

MEDNAX completes $250M accelerated share repurchase program

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


MEDNAX completes $250M accelerated share repurchase program

MEDNAX Inc. completed an accelerated share repurchase program for $250 million of its common stock.

Under the program, about 5.9 million common shares were repurchased at an average price of $42.47 apiece.

The accelerated repurchase program was launched as part of a $500 million share repurchase authorized by the company's board in August. As of Dec. 13, about $250 million was remaining under the authorization.

Sunrise, Fla.-based Mednax operates a national physician network and also provides services such as consulting and clinical specialties to healthcare facilities and physicians.